Suprainguinal Facia Iliaca Block in Maximizing the Feasibility of Positioning for Spinal Anesthesia

Effectiveness of Suprainguinal Facia Iliaca Block in Maximizing the Feasibility of Positioning for Spinal Anesthesia in Patients With Hip and Proximal Femur Fractures, a Placebo Randomized Controlled Study

In this study, we assessed the effect of suprainguinal facia iliaca block in maximizing the feasibility of positioning for spinal anaesthesia in patients with hip and proximal femur fractures by determining the angle that could be achieved and success rate of spinal anesthesia The control group received a sham block with the same technique of suprainguinal fascia iliaca block before being given spinal anaesthesia.

The interventional group received suprainguinal fascia iliaca block before being given spinal anaesthesia.

Study Overview

• Status: Completed
• Conditions: Spinal Anaesthesia; Spinal Anaesthetic Poisoning
• Intervention / Treatment: Drug: Bubpivacaine; Drug: Normal Saline

• Study Type: Interventional
• Enrollment (Actual): 40
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Ismailia, Egypt
    • Faculty of Medicine, Suez Canal University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Patients are ASA I (American Society of Anesthesiologists physical status grade I) = normal healthy patients, ASA II (American Society of Anesthesiologists physical status grade II) = patients with mild systemic disease and no functional limitations, or ASA III (American Society of Anesthesiologists physical status grade III) = patients with moderate systemic disease and some functional limitations.
• Patients having hip and/or proximal femur fractures.

Exclusion Criteria:

• Patient refusal to participate in the study
• Patients' refusal for regional anaesthesia
• Patients have other combined fractures rather than unilateral hip or proximal femur fractures.
• Underlying coagulopathies.
• Local infection.
• Known allergy to LA.
• Body mass index (BMI) more than 40 kg/m².
• Heart block greater than first-degree.
• Renal and hepatic dysfunction.
• Neurological diseases such as Alzheimer's and dementia or apparent psychological instability.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Fascia iliaca compartment block; Fascia iliaca block was performed at the pre-anaesthesia holding area 30 minutes before shifting the patients to the operation room with 30 ml of 0.5% bupivacaine.	Drug: Bubpivacaine; Fascia iliaca compartment block (FICB) was performed at the pre-anaesthesia holding area 30 minutes before shifting the patients to the operation room with 30 ml of 0.5% bupivacaine.
Sham Comparator: Sham group; Sham block was performed at the pre-anaesthesia holding area 30 minutes before shifting the patients to the operation room with 30 ml normal saline.	Drug: Normal Saline; Sham block was performed at the pre-anaesthesia holding area 30 minutes before shifting the patients to the operation room with 30 ml normal saline.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Degree of Fowler's position	Measure and compare the maximum tolerable degree of Fowler's position after fascia iliaca compartment block (FICB) and sham block in order to give spinal anaesthesia.	30 minutes after the fascia iliaca compartment block or sham block and till the full sitting position before spinal anaesthesia.

Collaborators and Investigators

• Sponsor: Suez Canal University

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2022
• Primary Completion (Actual): November 30, 2024
• Study Completion (Actual): January 30, 2026

Study Registration Dates

• First Submitted: May 12, 2026
• First Submitted That Met QC Criteria: May 12, 2026
• First Posted (Actual): May 18, 2026

Study Record Updates

• Last Update Posted (Actual): May 18, 2026
• Last Update Submitted That Met QC Criteria: May 12, 2026
• Last Verified: May 1, 2026

More Information

Terms related to this study

• Keywords: spinal anaesthesia positioning
• Additional Relevant MeSH Terms: Pharmaceutical Preparations; Crystalloid Solutions; Isotonic Solutions; Solutions; Saline Solution
• Other Study ID Numbers: Fascia Iliaca

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No